Home › Opioid Overdose › NCT07010978
Towards Testing the Effectiveness of Recovery Community Centers (RCCs)
R34 Study 2 - Pilot RCT Testing the Effectiveness of RCCs
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * 18+ years of age * Uses MOUD (at enrollment; participants may stop using MOUD subsequently) to treat OUD * Receives MOUD from a clinic/pharmacy located within 15 miles of an RCC vetted by our study team, which serves a Black community (i.e., defined as being located in a ZIP code where ≥27% of the residents are Black, as per US Census) * Is willing and able to engage in study procedures (i.e., online surveys, timeline follow back interview) * Is willing to be randomized Exclusion Criteria: \- Has visited a vetted RCC during the past 3 months
About the study
The goal of this pilot randomized clinical trial is to prepare for a larger randomized clinical trial (RCT) and collect some early data to learn if the intervention can help people who use medications for opioid use disorder (MOUD). The main questions it aims to answer are:
1. Is it feasible to recruit and randomize people to both treatment groups? 2. Does linking people to recovery community centers lead to better recovery outcomes?
Researchers will compare linking people to recovery community centers (RCC) to enhanced treatment as usual to see if recovery outcomes are different.
In one group, participants will learn about their local RCC and will be asked to visit their local RCC on at least two days and write about their experiences. In the other group, participants will learn about different recovery activities, pick any two, and do the activities of their choice on at least two days. They will also be asked to write about their experiences.
People in both groups will answer online survey questions about their recovery outcomes and well-being in five surveys over one year.
What is being tested
- Recovery Community Center Participation (behavioral)
- Enhance Treatment as Usual (behavioral)
Sponsor: Massachusetts General Hospital · Participants: 128 · Started: Aug 20, 2025
Contact the study team
- Bettina Hoeppner, Ph.D., M.S. · Phone: 617-643-1988
- Susanne Hoeppner, PhD, MApStat · Phone: 617-643-9934
Official record on ClinicalTrials.gov — NCT07010978
Locations in the U.S.
| Massachusetts | Massachusetts General Hospital, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.